Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Incremental cost-effectiveness of initial cataract surgery.

Brandon G Busbee1, Melissa M Brown, Gary C Brown

  • 1Center for Evidence-Based Health Care Economics, Wills Eye Hospital, Jefferson Medical College, Philadelphia, PA, USA.

Ophthalmology
|March 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study.

EClinicalMedicine·2023
Same author

Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration.

Ophthalmology. Retina·2023
Same author

Prevention Surpasses Treatment: 5-year Follow-Up, Cost-Utility, and Cost-Benefit of Zeaxanthin Therapy for Neovascular Age-Related Macular Degeneration.

Ophthalmology and therapy·2023
Same author

Preference-based comparison of quality of life associated with vision loss in Black and White ophthalmic populations in the US.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2022
Same author

Quality of life associated with no light perception vision.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2022
Same author

Re: Le et al.: Associations between age-related eye diseases and Charles Bonnet Syndrome in participants of the Age-Related Eye Disease Study 2: Report Number 26 (Ophthalmology. 2022;129:233-235).

Ophthalmology·2022

Initial cataract surgery is a cost-effective treatment, offering significant quality-adjusted life-years (QALYs) gained. This analysis demonstrates its value compared to other medical procedures.

Area of Science:

  • Ophthalmology
  • Health Economics
  • Medical Decision Making

Background:

  • Cataract surgery is a common procedure to restore vision.
  • Evaluating the economic value of medical interventions is crucial for healthcare resource allocation.

Purpose of the Study:

  • To conduct a cost-utility analysis of initial cataract surgery.
  • To compare the cost-effectiveness of cataract surgery against established benchmarks.

Main Methods:

  • Utilized computer-based econometric modeling and decision analysis.
  • Incorporated visual acuity data from the US National Cataract Patient Outcomes Research Team (PORT).
  • Synthesized complication rates and time-tradeoff utility values to calculate Quality-Adjusted Life-Years (QALYs).

Related Experiment Videos

Main Results:

  • Initial cataract surgery yielded a mean gain of 1.776 QALYs per patient.
  • After a 3% discount rate, 1.25 QALYs were gained, with a mean discounted cost of $2525 per patient.
  • The resulting cost per QALY gained was $2020.

Conclusions:

  • Initial cataract surgery demonstrates high cost-effectiveness compared to interventions in other medical fields.
  • Incorporating patient preferences into evidence-based medicine is vital for future healthcare evaluations.